Revealing a novel mode of action for an osteoporosis drug
(Medical Xpress)—Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, ...
Aug 14, 2014
0
0